Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $15.84B | $13.09B | +20.96% |
Cost of Revenue | $6.44B | $3.53B | +82.17% |
Operating Income | $2.9B | $4.61B | -37.02% |
Net Income | $633M | $1.38B | -54.10% |
EPS (Basic) | $1.18 | $7.90 | -85.06% |
EPS (Diluted) | $1.17 | $7.86 | -85.11% |
SG&A Expense | $3.59B | $2.55B | +40.79% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $90.91B | $90.27B | +0.71% |
Current Assets | $27.21B | $47.38B | -42.58% |
Current Liabilities | $21.52B | $17.1B | +25.85% |
Stockholders' Equity | $5.92B | $6.78B | -12.62% |
Cash & Equivalents | $9.3B | $34.25B | -72.84% |
Long-Term Debt | $62.65B | $61.54B | +1.79% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $3.15B | $5.17B | -39.15% |
Investing Cash Flow | $-434M | $1.15B | -137.84% |
Financing Cash Flow | $-4.36B | $20.3B | -121.46% |
D&A | $2.8B | $1.8B | +55.85% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 18.3% | 35.2% | -16.86% |
Net Margin | 4.0% | — | — |
ROE | 10.7% | — | — |
ROA | 0.7% | — | — |
Current Ratio | $1.264 | — | — |
Other companies in Biotechnology